Corgi ONTO 2x Daily ETF Earnings & Forecasts - Benzinga

SPY769.32 QQQ718.00 BTC/USD79,960.00−1.58%DIA524.75 GLD371.69 TLT81.19

Premium Services

Corgi ONTO 2x Daily ETF

ONTXBATS

Trade with Public

Trade with Public

$9.17

0.809.62%

Last update: Oct 28, 8:00 PM

Overview News Short Interest

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Corgi ONTO 2x Daily ETF Earnings & Forecasts

Corgi ONTO 2x Daily ETF (ONTX) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

Corgi ONTO 2x Daily ETF Guidance

Recent Earnings Results

Metric	Q3 '23	Q2 '23	Q1 '23	Q4 '22
Earnings Per Share (Non-GAAP)
Estimate	$-0.29	$-0.31	$-0.30	$-0.28
Actual	$-0.23	$-0.20	$-0.28	$-0.26
Surprise	+20.7%	+35.5%	+6.67%	+7.14%
Revenue
Estimate	$70000	$70000	$90000	$60000
Actual	$57000	$57000	$56000	$56000
Surprise	-18.6%	-18.6%	-37.8%	-6.67%

Earnings & Guidance News

PRO
Onconova Therapeutics Q3 2023 EPS $(0.23) Beats $(0.29) Estimate, Sales $57.00K Miss $70.00K Estimate

Onconova Therapeutics (NASDAQ:ONTX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.29) by 20.69 percent. This is a 11.54 percent increase over losses of $(0.26) per share

Benzinga Newsdesk

PRO
Onconova Therapeutics Q3 EPS $(0.23) Beats $(0.29) Estimate, Sales $57.00K Miss $70.00K Estimate

Onconova Therapeutics (NASDAQ:ONTX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.29) by 20.69 percent. This is a 11.54 percent increase over losses of $(0.26) per share

Benzinga Newsdesk

Earnings Scheduled For November 14, 2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue of $18.00 million.

Benzinga Insights

Onconova Therapeutics's Earnings: A Preview

Benzinga Insights

PRO
Onconova Therapeutics Q2 EPS $(0.20) Beats $(0.31) Estimate, Sales $57.00K Miss $70.00K Estimate

Onconova Therapeutics (NASDAQ:ONTX) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.31) by 35.48 percent. This is a 5.26 percent decrease over losses of $(0.19) per share

Benzinga Newsdesk

Earnings Scheduled For August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

Benzinga Insights

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q3	Nov 14, 2023	$-0.23	$-0.29	20.7 %
Q2	Aug 10, 2023	$-0.20	$-0.31	35.5 %
Q1	May 15, 2023	$-0.28	$-0.30	6.67 %
Q4	Mar 16, 2023	$-0.26	$-0.28	7.14 %

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %
Q3	Nov 14, 2023	$57.00K	$70.00K	-18.6 %
Q2	Aug 10, 2023	$57.00K	$70.00K	-18.6 %
Q1	May 15, 2023	$56.00K	$90.00K	-37.8 %
Q4	Mar 16, 2023	$56.00K	$60.00K	-6.67 %